English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Forbes
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
Trending
+
Pharmaceuticals
Patient Daily
| Apr 19, 2026
Roche and C4 Therapeutics announce new molecular glue partnership worth up to $1 billion
+
Pharmaceuticals
Patient Daily
| Apr 23, 2026
Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets
+
Pharmaceuticals
Patient Daily
| Apr 19, 2026
Insmed ends skin disease drug development after trial results fall short
Patient Daily
| Apr 23, 2026
Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
